Treatment of Advanced Cutaneous Squamous Cell Carcinomas with Epidermal Growth Factor Receptor Inhibitors

被引：14

作者：

Alter, M. ^{[1
]}

Satzger, I. ^{[1
]}

Mattern, A. ^{[1
]}

Kapp, A. ^{[1
]}

Gutzmer, R. ^{[1
]}

机构：

[1] Hannover Med Sch, Dept Dermatol & Allergy, Skin Canc Ctr Hannover, DE-30625 Hannover, Germany

来源：

DERMATOLOGY | 2013年 / 227卷 / 04期

关键词：

Epidermal growth factor receptor; Squamous cell carcinoma; Skin cancer; Medical tumor therapy; Dermatooncology; NONMELANOMA SKIN-CANCER; EGF RECEPTOR; PHASE-II; PLUS CETUXIMAB; NECK; HEAD; EXPRESSION; ACTIVATION; THERAPY; COMBINATION;

D O I：

10.1159/000355181

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

In advanced cutaneous squamous cell carcinoma (cSCC), efficient medical treatment options are limited in case surgery and radiotherapy failed, particularly since most patients are of higher age and suffer from comorbidities. In many tumor entities, the epidermal growth factor receptor (EGFR) has been established as an important therapeutic target, and blockade of EGFR signaling by monoclonal antibodies or small molecules achieves a therapeutic benefit. EGFR expression is also often dysregulated in cSCC. We report here two patients with advanced cSCC treated with the EGFR inhibitor cetuximab and summarize the current published experience with the use of EGFR inhibitors in cSCC. (C) 2013 S. Karger AG, Basel

引用

页码：289 / 294

页数：6

共 50 条

[21] Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas
Toll, Agusti
Salgado, Rocio
Yebenes, Mireia
Martin-Ezquerra, Gemma
Gilaberte, Montserrat
Baro, Teresa
Sole, Francesc
Alameda, Francisco
Espinet, Blanca
Maria Pujol, Ramon
EXPERIMENTAL DERMATOLOGY, 2010, 19 (02) : 151 - 153
[22] Dysregulated Expression of Phosphorylated Epidermal Growth Factor Receptor and Phosphatase and Tensin Homologue in Canine Cutaneous Papillomas and Squamous Cell Carcinomas
Sanz Ressel, B. L.
Massone, A. R.
Barbeito, C. G.
JOURNAL OF COMPARATIVE PATHOLOGY, 2020, 174 : 26 - 33
[23] Epidermal growth factor receptor-mutated lung carcinomas with insufficient response to epidermal growth factor receptor inhibitors
Moiseenko, Fedor
Kuligina, Ekaterina
Elsakova, Ekaterina
Imyanitov, Evgeny
FUTURE ONCOLOGY, 2024, 20 (31) : 2397 - 2407
[24] HYPERPRODUCTION AND GENE AMPLIFICATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN SQUAMOUS-CELL CARCINOMAS
HUNTS, J
UEDA, M
OZAWA, S
ABE, O
PASTAN, I
SHIMIZU, N
JAPANESE JOURNAL OF CANCER RESEARCH, 1985, 76 (08): : 663 - 666
[25] IMMUNOHISTOCHEMICAL DETECTION OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN LARYNGEAL SQUAMOUS-CELL CARCINOMAS
CHRISTENSEN, ME
THERKILDSEN, MH
HANSEN, BL
HANSEN, GN
BRETLAU, P
ACTA OTO-LARYNGOLOGICA, 1992, 112 (04) : 734 - 738
[26] Epidermal growth factor receptor (EGFR) mutated advanced squamous cell lung cancer - treatment beyond progression
O'Leary, C. G.
Corrigan, L.
Rehman, Z.
Kroes, J.
Murphy, G.
Mannion, J.
O'Connor, M.
Horgan, A.
Calvert, P.
LUNG CANCER, 2017, 103 : S6 - S6
[27] Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma
Canueto, J.
Cardenoso, E.
Garcia, J. L.
Santos-Briz, A.
Castellanos-Martin, A.
Fernandez-Lopez, E.
Blanco Gomez, A.
Perez-Losada, J.
Roman-Curto, C.
BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (05) : 1279 - 1287
[28] Somatic Mutation of Epidermal Growth Factor Receptor in a Small Subset of Cutaneous Squamous Cell Carcinoma
Ridd, Katie
Bastian, Boris C.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (03) : 901 - 903
[29] THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) IS FREQUENTLY OVEREXPRESSED IN PENILE SQUAMOUS CARCINOMAS
Netto, George
Cubilla, Antonio L.
Sharma, Rajni
Lecksell, Kristen
Katz, Betina
Chaux, Alcides
JOURNAL OF UROLOGY, 2012, 187 (04): : E378 - E378
[30] The Epidermal Growth Factor Receptor (EGFR) Is Frequently Overexpressed in Penile Squamous Carcinomas
Netto, G. J.
Cubilla, A. L.
Katz, B.
Lecksell, K. L.
Sharma, R.
Chaux, A.
LABORATORY INVESTIGATION, 2012, 92 : 231A - 231A

← 1 2 3 4 5 →